Angiotensin II receptor antagonist metabolite and NEP inhibitor composite and preparation method thereof
US11026925B2 · kind B2 · utility
0Cited by
2References
22Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 19, 2017 |
| Grant date | Jun 8, 2021 |
| Priority date | — |
| Expiry date | Jan 9, 2038 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided are a supramolecular composite comprising an angiotensin II receptor (AT1) blocking compound, a neutral endopeptidase inhibitor (NEPi), and a pharmaceutically acceptable cation. The invention further provides a method for preparing the composite and an application of the composite for preparing a pharmaceutical product for treating heart failure.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.